{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:51:20Z","timestamp":1790790680209,"version":"4.1.0"},"reference-count":143,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T00:00:00Z","timestamp":1524614400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00885","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T04:13:27Z","timestamp":1524629607000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Whodunit? The Contribution of Interleukin (IL)-17\/IL-22-Producing \u03b3\u03b4 T Cells, \u03b1\u03b2 T Cells, and Innate Lymphoid Cells to the Pathogenesis of Spondyloarthritis"],"prefix":"10.3389","volume":"9","author":[{"given":"Annika","family":"Reinhardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immo","family":"Prinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrrheum.2017.56","article-title":"Pathogenesis of ankylosing spondylitis\u2014recent advances and future directions","volume":"13","author":"Ranganathan","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.rdc.2012.09.003","article-title":"Epidemiology of spondyloarthritis","volume":"38","author":"Stolwijk","year":"2012","journal-title":"Rheum Dis Clin North Am"},{"key":"B3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nrrheum.2012.41","article-title":"Genetics of spondyloarthritis\u2014beyond the MHC","volume":"8","author":"Reveille","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/ng.2667","article-title":"Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci","volume":"45","author":"Cortes","year":"2013","journal-title":"Nat Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.molimm.2013.06.010","article-title":"The critical role of interleukin-23 in spondyloarthropathy","volume":"57","author":"Sherlock","year":"2014","journal-title":"Mol Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nrrheum.2015.128","article-title":"The IL-23-IL-17 axis in inflammatory arthritis","volume":"11","author":"Lubberts","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1136\/ard.2007.080283","article-title":"The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis","volume":"67","author":"Rueda","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/iji.12127","article-title":"IL-23R gene polymorphism rs2201841 is associated with psoriatic arthritis","volume":"41","author":"Popadic","year":"2014","journal-title":"Int J Immunogenet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1086\/511051","article-title":"A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am J Hum Genet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1126\/science.1135245","article-title":"A genome-wide association study identifies IL23R as an inflammatory bowel disease gene","volume":"314","author":"Duerr","year":"2006","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","article-title":"Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial","volume":"382","author":"Baeten","year":"2013","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1315231","article-title":"Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis","volume":"370","author":"Mease","year":"2014","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0140-6736(15)61134-5","article-title":"Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"386","author":"McInnes","year":"2015","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","article-title":"Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis","volume":"373","author":"Baeten","year":"2015","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13075-017-1249-5","article-title":"Mechanistic rationales for targeting interleukin-17A in spondyloarthritis","volume":"19","author":"Raychaudhuri","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/annrheumdis-2016-209709","article-title":"Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1","volume":"76","author":"Mease","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2017.00001","article-title":"Anti-IL17A in axial spondyloarthritis-where are we at?","volume":"4","author":"Cheung","year":"2017","journal-title":"Front Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1136\/annrheumdis-2013-204248","article-title":"Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)","volume":"73","author":"Poddubnyy","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1136\/annrheumdis-2013-204655","article-title":"Efficacy and safety of the anti-IL-12\/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial","volume":"73","author":"Ritchlin","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1136\/annrheumdis-2015-209068","article-title":"Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1\/PSUMMIT-2)","volume":"75","author":"Kavanaugh","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10067-017-3953-6","article-title":"Effectiveness and safety of ustekinumab in naive or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study","volume":"37","author":"Chimenti","year":"2018","journal-title":"Clin Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"ii38","DOI":"10.1093\/rheumatology\/kew349","article-title":"New treatment targets for axial spondyloarthritis","volume":"55","author":"Sieper","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex361","article-title":"What is the best treatment target in axial spondyloarthritis: tumour necrosis factor alpha, interleukin 17, or both?","author":"Poddubnyy","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.semarthrit.2017.04.005","article-title":"Switching tumor necrosis factor inhibitors in the treatment of axial spondyloarthritis","volume":"47","author":"Deodhar","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"B25","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2017.188","article-title":"Enthesitis: from pathophysiology to treatment","volume":"13","author":"Schett","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/art.22290","article-title":"Microdamage and altered vascularity at the enthesis-bone interface provides an anatomic explanation for bone involvement in the HLA-B27-associated spondyloarthritides and allied disorders","volume":"56","author":"Benjamin","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B27","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.berh.2014.10.009","article-title":"The role of mechanical stress in the pathogenesis of spondyloarthritis and how to combat it","volume":"28","author":"Jacques","year":"2014","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/art.39458","article-title":"Review: enthesitis: new insights into pathogenesis, diagnostic modalities, and treatment","volume":"68","author":"Kehl","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1046\/j.1469-7580.2001.19950503.x","article-title":"The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites","volume":"199","author":"Benjamin","year":"2001","journal-title":"J Anat"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1002\/art.20566","article-title":"The \u201centhesis organ\u201d concept: why enthesopathies may not present as focal insertional disorders","volume":"50","author":"Benjamin","year":"2004","journal-title":"Arthritis Rheum"},{"key":"B31","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/BOR.0b013e3283620163","article-title":"The role of natural killer cells, gamma delta T-cells and other innate immune cells in spondyloarthritis","volume":"25","author":"Al-Mossawi","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11926-015-0507-2","article-title":"IL-23 responsive innate-like T cells in spondyloarthritis: the less frequent they are, the more vital they appear","volume":"17","author":"Venken","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jbspin.2006.11.005","article-title":"Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis","volume":"74","author":"Wendling","year":"2007","journal-title":"Joint Bone Spine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00296-009-0883-x","article-title":"Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis","volume":"29","author":"Wang","year":"2009","journal-title":"Rheumatol Int"},{"key":"B35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10067-010-1647-4","article-title":"Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis","volume":"30","author":"Mei","year":"2011","journal-title":"Clin Rheumatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00296-010-1655-3","article-title":"Increased plasma levels of IL-21 and IL-23 in spondyloarthritis are not associated with clinical and MRI findings","volume":"32","author":"Andersen","year":"2012","journal-title":"Rheumatol Int"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1002\/art.37937","article-title":"In situ analysis of interleukin-23- and interleukin-12-positive cells in the spine of patients with ankylosing spondylitis","volume":"65","author":"Appel","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/art.33396","article-title":"Interleukin-17-positive mast cells contribute to synovial inflammation in spondyloarthritis","volume":"64","author":"Noordenbos","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B39","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1186\/ar3370","article-title":"Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response","volume":"13","author":"Appel","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1002\/eji.201242569","article-title":"IL-17-producing gammadelta T cells and innate lymphoid cells","volume":"42","author":"Sutton","year":"2012","journal-title":"Eur J Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.immuni.2012.06.003","article-title":"Development of interleukin-17-producing gammadelta T cells is restricted to a functional embryonic wave","volume":"37","author":"Haas","year":"2012","journal-title":"Immunity"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1002\/eji.201343759","article-title":"Functional development of gammadelta T cells","volume":"43","author":"Prinz","year":"2013","journal-title":"Eur J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1182\/blood-2011-01-331298","article-title":"Differentiation, phenotype, and function of interleukin-17-producing human Vgamma9Vdelta2 T cells","volume":"118","author":"Caccamo","year":"2011","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/art.40050","article-title":"Reply","volume":"69","author":"Reinhardt","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3389\/fimmu.2017.00761","article-title":"Key features of gamma-delta T-cell subsets in human diseases and their immunotherapeutic implications","volume":"8","author":"Lawand","year":"2017","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jaut.2017.11.006","article-title":"Innately versatile: gammadelta17 T cells in inflammatory and autoimmune diseases","volume":"87","author":"Papotto","year":"2017","journal-title":"J Autoimmun"},{"key":"B47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0090-1229(91)90090-W","article-title":"Gamma\/delta T cells and their subpopulations in blood and synovial fluid from rheumatoid arthritis and spondyloarthritis","volume":"59","author":"Meliconi","year":"1991","journal-title":"Clin Immunol Immunopathol"},{"key":"B48","first-page":"78","article-title":"Elevation of a gamma delta T cell subset in peripheral blood and synovial fluid of patients with rheumatoid arthritis","volume":"84","author":"Keystone","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"B49","first-page":"239","article-title":"Different circulating lymphocyte profiles in patients with different subtypes of juvenile idiopathic arthritis","volume":"20","author":"Wouters","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"B50","first-page":"389","article-title":"Natural killer cells and gamma\/delta T cells in synovial fluid and in peripheral blood of patients with psoriatic arthritis","volume":"22","author":"Spadaro","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.clim.2009.09.010","article-title":"Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states","volume":"134","author":"Macaubas","year":"2010","journal-title":"Clin Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"R277","DOI":"10.1186\/ar791","article-title":"An association between the acute phase response and patterns of antigen induced T cell proliferation in juvenile idiopathic arthritis","volume":"5","author":"Black","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"B53","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.4049\/jimmunol.1102403","article-title":"Cellular interactions of synovial fluid gammadelta T cells in juvenile idiopathic arthritis","volume":"188","author":"Bendersky","year":"2012","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/art.33507","article-title":"Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive gamma\/delta T cells in patients with active ankylosing spondylitis","volume":"64","author":"Kenna","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B55","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.clim.2015.07.012","article-title":"Natural killer cell and gamma delta T cell alterations in enthesitis related arthritis category of juvenile idiopathic arthritis","volume":"161","author":"Gaur","year":"2015","journal-title":"Clin Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.clim.2017.03.016","article-title":"IL-17 and IFN-gamma producing NK and gammadelta-T cells are preferentially expanded in synovial fluid of patients with reactive arthritis and undifferentiated spondyloarthritis","volume":"183","author":"Chowdhury","year":"2017","journal-title":"Clin Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/art.40099","article-title":"Proinflammatory cytokine environments can drive interleukin-17 overexpression by gamma\/delta T cells in systemic juvenile idiopathic arthritis","volume":"69","author":"Kessel","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/cei.12853","article-title":"Interleukin (IL)-9\/IL-9R axis drives gammadelta T cells activation in psoriatic arthritis patients","volume":"186","author":"Guggino","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"R194","DOI":"10.1186\/ar2893","article-title":"Interleukin-23 is critical for full-blown expression of a non-autoimmune destructive arthritis and regulates interleukin-17A and RORgammat in gammadelta T cells","volume":"11","author":"Cornelissen","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B60","doi-asserted-by":"publisher","first-page":"E3669","DOI":"10.1073\/pnas.1405798111","article-title":"Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice","volume":"111","author":"Khmaladze","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/art.38359","article-title":"Systemic juvenile idiopathic arthritis-like syndrome in mice following stimulation of the immune system with Freund\u2019s complete adjuvant: regulation by interferon-gamma","volume":"66","author":"Avau","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"7464","DOI":"10.1038\/ncomms8464","article-title":"IL-1 receptor antagonist-deficient mice develop autoimmune arthritis due to intrinsic activation of IL-17-producing CCR2(+)Vgamma6(+)gammadelta T cells","volume":"6","author":"Akitsu","year":"2015","journal-title":"Nat Commun"},{"key":"B63","doi-asserted-by":"publisher","first-page":"951","DOI":"10.4049\/jimmunol.1003986","article-title":"IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass","volume":"187","author":"Adamopoulos","year":"2011","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1002\/art.39732","article-title":"Interleukin-23-dependent gamma\/delta T cells produce interleukin-17 and accumulate in the enthesis, aortic valve, and ciliary body in mice","volume":"68","author":"Reinhardt","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/1529-0131(200004)43:4<844::AID-ANR15>3.0.CO;2-B","article-title":"T lymphocytes are not required for the spontaneous development of entheseal ossification leading to marginal ankylosis in the DBA\/1 mouse","volume":"43","author":"Corthay","year":"2000","journal-title":"Arthritis Rheum"},{"key":"B67","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.4049\/jimmunol.172.6.3573","article-title":"A keratinocyte-responsive gamma delta TCR is necessary for dendritic epidermal T cell activation by damaged keratinocytes and maintenance in the epidermis","volume":"172","author":"Jameson","year":"2004","journal-title":"J Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1002\/art.40150","article-title":"Brief report: group 3 innate lymphoid cells in human enthesis","volume":"69","author":"Cuthbert","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nature14189","article-title":"The biology of innate lymphoid cells","volume":"517","author":"Artis","year":"2015","journal-title":"Nature"},{"key":"B70","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ni.3489","article-title":"Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis","volume":"17","author":"Klose","year":"2016","journal-title":"Nat Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nri.2017.86","article-title":"Innate lymphoid cells: major players in inflammatory diseases","volume":"17","author":"Ebbo","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/art.40068","article-title":"Review: innate lymphoid cells: sparking inflammatory rheumatic disease?","volume":"69","author":"Wenink","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.4049\/jimmunol.1700596","article-title":"Cutting edge: homeostasis of innate lymphoid cells is imbalanced in psoriatic arthritis","volume":"200","author":"Soare","year":"2018","journal-title":"J Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.imlet.2016.07.004","article-title":"Innate lymphoid cells, precursors and plasticity","volume":"179","author":"Gronke","year":"2016","journal-title":"Immunol Lett"},{"key":"B75","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.immuni.2015.06.019","article-title":"Interleukin-12 and -23 control plasticity of CD127(+) group 1 and group 3 innate lymphoid cells in the intestinal lamina propria","volume":"43","author":"Bernink","year":"2015","journal-title":"Immunity"},{"key":"B76","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ni.3078","article-title":"IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential \u2018inflammatory\u2019 type 2 innate lymphoid cells","volume":"16","author":"Huang","year":"2015","journal-title":"Nat Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1002\/art.39261","article-title":"Brief report: enrichment of activated group 3 innate lymphoid cells in psoriatic arthritis synovial fluid","volume":"67","author":"Leijten","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1038\/s41467-017-01771-2","article-title":"Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis","volume":"8","author":"Al-Mossawi","year":"2017","journal-title":"Nat Commun"},{"key":"B79","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jbspin.2016.02.017","article-title":"The gut in spondyloarthritis","volume":"83","author":"Wendling","year":"2016","journal-title":"Joint Bone Spine"},{"key":"B80","first-page":"2279","article-title":"The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint","volume":"22","author":"Mielants","year":"1995","journal-title":"J Rheumatol"},{"key":"B81","first-page":"1085","article-title":"Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis","volume":"34","author":"Triggianese","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1002\/art.34355","article-title":"Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis","volume":"64","author":"Ciccia","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1136\/annrheumdis-2014-206323","article-title":"Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis","volume":"74","author":"Ciccia","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B84","first-page":"1932","article-title":"Enrichment of T cells carrying beta7 integrins in inflamed synovial tissue from patients with early spondyloarthropathy, compared to rheumatoid arthritis","volume":"25","author":"Elewaut","year":"1998","journal-title":"J Rheumatol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1136\/annrheumdis-2015-207735","article-title":"Spreading spondyloarthritis: are ILCs cytokine shuttles from base camp gut?","volume":"74","author":"Neerinckx","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B86","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nature11813","article-title":"A T-bet gradient controls the fate and function of CCR6-RORgammat+ innate lymphoid cells","volume":"494","author":"Klose","year":"2013","journal-title":"Nature"},{"key":"B87","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1126\/science.aac9593","article-title":"Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs","volume":"350","author":"Gasteiger","year":"2015","journal-title":"Science"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.cell.2016.02.048","article-title":"Hallmarks of tissue-resident lymphocytes","volume":"164","author":"Fan","year":"2016","journal-title":"Cell"},{"key":"B89","doi-asserted-by":"publisher","first-page":"5862","DOI":"10.1038\/ncomms6862","article-title":"CCR7-dependent trafficking of RORgamma(+) ILCs creates a unique microenvironment within mucosal draining lymph nodes","volume":"6","author":"Mackley","year":"2015","journal-title":"Nat Commun"},{"key":"B90","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cellimm.2013.08.005","article-title":"Constitutive expression of ligand for natural killer cell NKp44 receptor (NKp44L) by normal human articular chondrocytes","volume":"285","author":"Bialoszewska","year":"2013","journal-title":"Cell Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1172\/JCI9295","article-title":"CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis","volume":"106","author":"Fiorillo","year":"2000","journal-title":"J Clin Invest"},{"key":"B92","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/art.40028","article-title":"Discovery of T cell receptor beta motifs specific to HLA-B27-positive ankylosing spondylitis by deep repertoire sequence analysis","volume":"69","author":"Faham","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1136\/ard.60.4.316","article-title":"Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis","volume":"60","author":"Laloux","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/art.22060","article-title":"Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis","volume":"54","author":"Appel","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.4049\/jimmunol.170.2.1099","article-title":"CD8 alpha beta T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats","volume":"170","author":"May","year":"2003","journal-title":"J Immunol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1002\/art.24599","article-title":"Spondyloarthritis in HLA-B27\/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8","volume":"60","author":"Taurog","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B97","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.4049\/jimmunol.162.9.5045","article-title":"Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure","volume":"162","author":"Allen","year":"1999","journal-title":"J Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1002\/art.10605","article-title":"Cell-surface expression and immune receptor recognition of HLA-B27 homodimers","volume":"46","author":"Kollnberger","year":"2002","journal-title":"Arthritis Rheum"},{"key":"B99","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/art.39515","article-title":"Activation-induced killer cell immunoglobulin-like receptor 3DL2 binding to HLA-B27 licenses pathogenic T cell differentiation in spondyloarthritis","volume":"68","author":"Ridley","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/rheumatology\/keu382","article-title":"IL-17-producing CD4+ T cells are increased in early, active axial spondyloarthritis including patients without imaging abnormalities","volume":"54","author":"Jansen","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.4049\/jimmunol.1002653","article-title":"Th17\u2009cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis","volume":"186","author":"Bowness","year":"2011","journal-title":"J Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e105684","DOI":"10.1371\/journal.pone.0105684","article-title":"HLA-B27 and human beta2-microglobulin affect the gut microbiota of transgenic rats","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"key":"B103","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/art.38967","article-title":"Brief report: intestinal dysbiosis in ankylosing spondylitis","volume":"67","author":"Costello","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1136\/annrheumdis-2016-211064","article-title":"Faecal microbiota study reveals specific dysbiosis in spondyloarthritis","volume":"76","author":"Breban","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B105","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/art.40359","article-title":"Gut microbiota perturbations in reactive arthritis and postinfectious spondyloarthritis","volume":"70","author":"Manasson","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1002\/art.24763","article-title":"HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats","volume":"60","author":"DeLay","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1136\/annrheumdis-2012-202925","article-title":"Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation","volume":"73","author":"Ciccia","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B108","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/art.40405","article-title":"Effects of HLA-B27 on gut microbiota in experimental spondyloarthritis implicate an ecological model of dysbiosis","volume":"70","author":"Gill","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"eaaf9655","DOI":"10.1126\/scitranslmed.aaf9655","article-title":"IgA-coated E. coli enriched in Crohn\u2019s disease spondyloarthritis promote TH17-dependent inflammation","volume":"9","author":"Viladomiu","year":"2017","journal-title":"Sci Transl Med"},{"key":"B110","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1002\/art.39681","article-title":"Pertur-bed mucosal immunity and dysbiosis accompany clinical disease in a rat model of spondyloarthritis","volume":"68","author":"Asquith","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/rheumatology\/kes267","article-title":"Decreased Th17 and Th1\u2009cells in the peripheral blood of patients with early non-radiographic axial spondyloarthritis: a marker of disease activity in HLA-B27(+) patients","volume":"52","author":"Bautista-Caro","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"B112","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/art.23655","article-title":"Increased numbers of circulating polyfunctional Th17 memory cells in patients with sero-negative spondyloarthritides","volume":"58","author":"Jandus","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B113","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/art.23291","article-title":"Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers","volume":"58","author":"Nistala","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B114","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.3899\/jrheum.100146","article-title":"Frequency and phenotype of T helper 17 cells in peripheral blood and synovial fluid of patients with reactive arthritis","volume":"37","author":"Shen","year":"2010","journal-title":"J Rheumatol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10875-012-9774-0","article-title":"Levels of circulating Th17\u2009cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-alpha therapy","volume":"33","author":"Xueyi","year":"2013","journal-title":"J Clin Immunol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"R136","DOI":"10.1186\/ar4317","article-title":"Th17 and Th22 cells in psoriatic arthritis and psoriasis","volume":"15","author":"Benham","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B117","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10067-016-3500-x","article-title":"Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F(+)IL-23(+) CD161(+) CD4(+) T helper cells in psoriatic arthritis joints","volume":"36","author":"Fiocco","year":"2017","journal-title":"Clin Rheumatol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/art.39464","article-title":"Sexual dimorphism in the Th17 signature of ankylosing spondylitis","volume":"68","author":"Gracey","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/annrheumdis-2016-210175","article-title":"miR-10b-5p is a novel Th17 regulator present in Th17\u2009cells from ankylosing spondylitis","volume":"76","author":"Chen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B120","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clim.2017.04.010","article-title":"IL-10 producing Bregs are impaired in psoriatic arthritis and psoriasis and inversely correlate with IL-17- and IFNgamma-producing T cells","volume":"184","author":"Mavropoulos","year":"2017","journal-title":"Clin Immunol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1002\/art.27699","article-title":"Expansion of intestinal CD4+CD25(high) Treg cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response","volume":"62","author":"Ciccia","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B122","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1365-3083.2006.001755.x","article-title":"FOXP3 identifies regulatory CD25bright CD4+ T cells in rheumatic joints","volume":"63","author":"Cao","year":"2006","journal-title":"Scand J Immunol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.3899\/jrheum.110377","article-title":"Synovial and peripheral blood CD4+FoxP3+ T cells in spondyloarthritis","volume":"38","author":"Appel","year":"2011","journal-title":"J Rheumatol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"37559","DOI":"10.1038\/srep37559","article-title":"Functional defects in CD4(+) CD25(high) FoxP3(+) regulatory cells in ankylosing spondylitis","volume":"6","author":"Guo","year":"2016","journal-title":"Sci Rep"},{"key":"B125","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1002\/art.38737","article-title":"Increased production of interleukin-17 over interleukin-10 by Treg cells implicates inducible costimulator molecule in experimental spondyloarthritis","volume":"66","author":"Araujo","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1136\/annrheumdis-2015-208677","article-title":"Genetic association of ankylosing spondylitis with TBX21 influences T-bet and pro-inflammatory cytokine expression in humans and SKG mice as a model of spondyloarthritis","volume":"76","author":"Lau","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.3899\/jrheum.151133","article-title":"Involvement of mucosal-associated invariant T cells in ankylosing spondylitis","volume":"43","author":"Hayashi","year":"2016","journal-title":"J Rheumatol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1136\/annrheumdis-2015-208902","article-title":"IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis","volume":"75","author":"Gracey","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B129","doi-asserted-by":"publisher","first-page":"974","DOI":"10.4049\/jimmunol.1701213","article-title":"Production of IL-17 by MAIT cells is increased in multiple sclerosis and is associated with IL-7 receptor expression","volume":"200","author":"Willing","year":"2018","journal-title":"J Immunol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1136\/annrheumdis-2016-209695","article-title":"MAIT cells: not just another brick in the wall","volume":"75","author":"Debusschere","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B131","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/BOR.0000000000000301","article-title":"Targeting the interleukin-23\/17 axis in axial spondyloarthritis","volume":"28","author":"Paine","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.berh.2016.02.002","article-title":"New immune cells in spondyloarthritis: key players or innocent bystanders?","volume":"29","author":"Venken","year":"2015","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nrrheum.2016.140","article-title":"What rheumatologists need to know about innate lymphocytes","volume":"12","author":"Exley","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"13850","DOI":"10.1038\/ncomms13850","article-title":"Innate and adaptive immune traits are differentially affected by genetic and environmental factors","volume":"8","author":"Mangino","year":"2017","journal-title":"Nat Commun"},{"key":"B135","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/annrheumdis-2013-203643","article-title":"Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells","volume":"73","author":"Jacques","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/art.38636","article-title":"Animal models of spondyloarthritis: do they faithfully mirror human disease?","volume":"66","author":"Breban","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1002\/art.39282","article-title":"Review: animal models as a tool to dissect pivotal pathways driving spondyloarthritis","volume":"67","author":"Vieira-Sousa","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1136\/ard.2009.107649","article-title":"Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis","volume":"69","author":"Melis","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/annrheumdis-2016-210000","article-title":"Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis","volume":"76","author":"Ciccia","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B140","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nm.4068","article-title":"Commensal microbiota affects ischemic stroke outcome by regulating intestinal gammadelta T cells","volume":"22","author":"Benakis","year":"2016","journal-title":"Nat Med"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1161\/STROKEAHA.117.016753","article-title":"CCR6 (CC chemokine receptor 6) is essential for the migration of detrimental natural interleukin-17-producing gammadelta T cells in stroke","volume":"48","author":"Arunachalam","year":"2017","journal-title":"Stroke"},{"key":"B142","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.jbspin.2015.10.015","article-title":"Trafficking of antigens from gut to sacroiliac joints and spine in reactive arthritis and spondyloarthropathies: mainly through lymphatics?","volume":"83","author":"Berthelot","year":"2016","journal-title":"Joint Bone Spine"},{"key":"B143","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/eji.201747195","article-title":"CXCL4 is a novel inducer of human Th17\u2009cells and correlates with IL-17 and IL-22 in psoriatic arthritis","volume":"48","author":"Affandi","year":"2018","journal-title":"Eur J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00885\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T08:18:37Z","timestamp":1693642717000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00885\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,25]]},"references-count":143,"alternative-id":["10.3389\/fimmu.2018.00885"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00885","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,25]]},"article-number":"885"}}